I’m as disappointed as most with the share price, but you can’t build a billion company when 76% is owned by retail, look we got to get realistic, top twenty should hold at least 60%, that way, it’s under lock and key.
Trial results are only a quick fix in the share price, before a sell down begins, partner up Orth-ATI, Celgro Nerve and we will see institutional investment buy ins and big increases in share price
You can’t beat the rinse repeat cycle getting played, sure a good time to buy in a hope for a few cents profit after the next announcement
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-122
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.5¢ | $17.64K | 45.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23269 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |
Day chart unavailable